Jeffery C. Giering, Ph.D.

Mark A. Kay	grad student	2008	Stanford
(Development of a safe and effective polymerase II promoter-based short-hairpin RNA model therapeutic.)

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Giering JC, Grimm D, Storm TA, et al. (2008) Expression of shRNA from a tissue-specific pol II promoter is an effective and safe RNAi therapeutic. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1630-6
Ehrhardt A, Yant SR, Giering JC, et al. (2007) Somatic integration from an adenoviral hybrid vector into a hot spot in mouse liver results in persistent transgene expression levels in vivo. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 146-56
Giering JC, Grimm D, Storm TA, et al. (2006) 796. Pol II-Driven shRNA as an Effective Hepatitis B Virus Therapeutic Molecular Therapy. 13: S308-S309
Giering JC, Kay MA. (2005) 88. Driving shRNA Transcription from PolII Promoters in Mammalian Cells Molecular Therapy. 11